SG11201500346QA - Low-volume coagulation assay - Google Patents

Low-volume coagulation assay

Info

Publication number
SG11201500346QA
SG11201500346QA SG11201500346QA SG11201500346QA SG11201500346QA SG 11201500346Q A SG11201500346Q A SG 11201500346QA SG 11201500346Q A SG11201500346Q A SG 11201500346QA SG 11201500346Q A SG11201500346Q A SG 11201500346QA SG 11201500346Q A SG11201500346Q A SG 11201500346QA
Authority
SG
Singapore
Prior art keywords
low
coagulation assay
volume coagulation
volume
assay
Prior art date
Application number
SG11201500346QA
Inventor
Mark Dayel
Samartha Anekal
Paul Patel
Ian Gibbons
Elizabeth Holmes
Original Assignee
Theranos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theranos Inc filed Critical Theranos Inc
Publication of SG11201500346QA publication Critical patent/SG11201500346QA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84Systems specially adapted for particular applications
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/4905Determining clotting time of blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745Assays involving non-enzymic blood coagulation factors
    • G01N2333/75Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Ecology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
SG11201500346QA 2012-07-18 2013-07-18 Low-volume coagulation assay SG11201500346QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261673227P 2012-07-18 2012-07-18
PCT/US2013/051162 WO2014015191A2 (en) 2012-07-18 2013-07-18 Low-volume coagulation assay

Publications (1)

Publication Number Publication Date
SG11201500346QA true SG11201500346QA (en) 2015-02-27

Family

ID=49949383

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201500346QA SG11201500346QA (en) 2012-07-18 2013-07-18 Low-volume coagulation assay
SG10201603916UA SG10201603916UA (en) 2012-07-18 2013-07-18 Low-Volume Coagulation Assay

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201603916UA SG10201603916UA (en) 2012-07-18 2013-07-18 Low-Volume Coagulation Assay

Country Status (13)

Country Link
US (4) US9500639B2 (en)
EP (1) EP2875146B1 (en)
JP (4) JP2015528911A (en)
KR (1) KR102149318B1 (en)
CN (2) CN104662163A (en)
AU (1) AU2013292392A1 (en)
BR (1) BR112015001048B1 (en)
CA (2) CA2878875C (en)
HK (1) HK1210812A1 (en)
IL (1) IL236768B (en)
MX (1) MX360564B (en)
SG (2) SG11201500346QA (en)
WO (1) WO2014015191A2 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9500639B2 (en) 2012-07-18 2016-11-22 Theranos, Inc. Low-volume coagulation assay
JP2016532876A (en) 2013-09-06 2016-10-20 セラノス, インコーポレイテッド Equipment, systems, methods and kits for receiving wipes
US10823743B1 (en) 2013-10-28 2020-11-03 Ifirst Medical Technologies, Inc. Methods of measuring coagulation of a biological sample
EP2975383A1 (en) * 2014-07-14 2016-01-20 Johann Wolfgang Goethe-Universität, Frankfurt am Main Method and device for analyzing a fluid medium such as a blood sample
FR3024237B1 (en) * 2014-07-25 2016-08-05 Stago Diagnostica METHOD OF DETERMINING THE STRUCTURAL PROFILE OF A FIBRIN FOOTBALL, REFLECTING ITS STABILITY, TO PREDICT THE RISK OF BLEEDING, THROMBOSIS OR RE-THROMBOSIS
ES2881861T3 (en) 2014-09-26 2021-11-30 Abbott Point Of Care Inc Sensors to evaluate coagulation in fluid samples
US10048281B2 (en) 2014-09-26 2018-08-14 Abbott Point Of Care Inc. Cartridge device with segmented fluidics for assaying coagulation in fluid samples
CN107107057B (en) 2014-09-26 2020-12-15 雅培医护站股份有限公司 Cassette device identification for coagulation assays in fluid samples
CN107110875A (en) 2014-09-26 2017-08-29 雅培医护站股份有限公司 Ellagic acid preparation in solidification measure
EP3198270A1 (en) 2014-09-26 2017-08-02 Abbott Point Of Care, Inc. Cartridge device with fluidic junctions for coagulation assays in fluid samples
EP3197602B1 (en) 2014-09-26 2021-09-01 Abbott Point Of Care, Inc. Microfabricated device with micro-environment sensors for assaying coagulation in fluid samples
ES2911898T3 (en) 2014-09-26 2022-05-23 Abbott Point Of Care Inc Single channel cartridge device for blood coagulation assays on fluid samples
CN107810412B (en) * 2015-06-29 2020-06-23 Ca卡西索有限公司 Blood testing system and method
AU2017250570B2 (en) 2016-04-15 2024-07-25 Takeda Pharmaceutical Company Limited Method and apparatus for providing a pharmacokinetic drug dosing regiment
EP3526582B1 (en) * 2016-10-14 2022-06-01 Commissariat à l'Énergie Atomique et aux Énergies Alternatives Method for characterising a sample comprising particles
US10896749B2 (en) 2017-01-27 2021-01-19 Shire Human Genetic Therapies, Inc. Drug monitoring tool
US10976305B2 (en) * 2017-04-27 2021-04-13 The University Of Chicago Coagulation testing in underfilled patient samples
CN108956542A (en) * 2017-05-18 2018-12-07 微采视像科技股份有限公司 The measuring method and its application apparatus of prothrombin time
US20210302412A1 (en) * 2018-07-25 2021-09-30 Ifirst Medical Technologies, Inc. Medical analyzer and diagnostic sample profiler
CN108982865B (en) * 2018-08-16 2021-05-11 上海原科实业发展有限公司 Thrombus elastography heparin quantitative detection kit and preparation method thereof
WO2020037670A1 (en) * 2018-08-24 2020-02-27 深圳迈瑞生物医疗电子股份有限公司 Blood sample analyzer and blood sample homogenization method
JP7135620B2 (en) * 2018-09-07 2022-09-13 ソニーグループ株式会社 Blood coagulation system analysis device, blood coagulation system analysis method, and blood coagulation system analysis program
CN109211729A (en) * 2018-10-29 2019-01-15 杨忠思 A kind of blood stagnation condition checkout gear and method for precisely medical treatment detection
CA3153941A1 (en) * 2019-10-17 2021-04-22 Mary POMEROY Coagulation assay apparatus and methods thereof
EP4087939A1 (en) * 2020-01-08 2022-11-16 DSM IP Assets B.V. Combination of clot-based fibrinogen test and enzyme-based fibrinogen test
CN113777332B (en) * 2020-06-09 2024-06-18 深圳迈瑞生物医疗电子股份有限公司 Immunoassay instrument and autoimmune analysis method
CN116113831A (en) * 2020-06-23 2023-05-12 布里格姆妇女医院 Single molecule analysis for ultrasensitive detection of biomolecules
TWI819402B (en) * 2020-12-22 2023-10-21 財團法人工業技術研究院 System and method for monitoring and controlling multi-phase condition of reactant in manufacturing process
WO2024091477A1 (en) * 2022-10-24 2024-05-02 The Johns Hopkins University Mini-scale euglobulin clot lysis assays and methods of using the same

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4121466A (en) * 1977-04-19 1978-10-24 Technicon Instruments Corporation Liquid dispenser with an improved probe
US5164598A (en) 1985-08-05 1992-11-17 Biotrack Capillary flow device
US5134229A (en) * 1990-01-12 1992-07-28 Johnson & Johnson Medical, Inc. Process for preparing a neutralized oxidized cellulose product and its method of use
US5840573A (en) * 1994-02-01 1998-11-24 Fields; Robert E. Molecular analyzer and method of use
PT983788E (en) * 1994-06-16 2004-07-30 Dade Behring Marburg Gmbh METHOD AND DEVICE FOR MIXING LIQUIDS
EP1004870A1 (en) * 1998-11-09 2000-05-31 Aurora Biosciences Corporation Liquid barriers for assays
US6582964B1 (en) 1999-05-12 2003-06-24 Cme Telemetrix Inc. Method and apparatus for rapid measurement of HbA1c
US7130046B2 (en) 2004-09-27 2006-10-31 Honeywell International Inc. Data frame selection for cytometer analysis
JP4384344B2 (en) * 2000-08-09 2009-12-16 拓之 今野 Blood coagulation time measurement method and apparatus using granular spot pattern by laser reflected light
US6432658B1 (en) 2000-09-13 2002-08-13 Affinity Biologicals, Inc. Method for measuring antithrombin activity
JP2002214241A (en) * 2000-11-20 2002-07-31 Minolta Co Ltd Microchip
US20030116447A1 (en) 2001-11-16 2003-06-26 Surridge Nigel A. Electrodes, methods, apparatuses comprising micro-electrode arrays
AU2003303522B2 (en) * 2002-12-31 2009-05-28 Marine Polymer Technologies, Inc. Hemostatic compositions and uses therefor
DK1662987T3 (en) 2003-09-11 2012-02-27 Theranos Inc Medical device for analyte monitoring and drug delivery
WO2005049826A1 (en) 2003-11-22 2005-06-02 Ultizyme International Ltd. Method of detecting target molecule by using aptamer
US7399637B2 (en) * 2004-04-19 2008-07-15 Medtronic, Inc. Blood coagulation test cartridge, system, and method
EP1745145A4 (en) 2004-05-11 2008-03-26 Heptest Lab Inc Compositions, kit and one-step method for monitoring compounds having anti-factor xa and/or anti factor iia activities
CN101010579A (en) 2004-07-27 2007-08-01 株式会社三菱化学药得论 Method of auto-discrimination of test sample
US7544514B2 (en) * 2004-12-27 2009-06-09 David Varon Method and system for determining platelet-mediated clot formation
US8029783B2 (en) 2005-02-02 2011-10-04 Genentech, Inc. DR5 antibodies and articles of manufacture containing same
AU2006235025A1 (en) 2005-04-04 2006-10-19 The Regents Of The University Of California Inorganic materials for hemostatic modulation and therapeutic wound healing
AU2006242354B2 (en) * 2005-04-29 2012-03-15 University Of Louisville Research Foundation, Inc. Cell-surface decoration with active agents
CA2610294C (en) 2005-05-09 2023-10-03 Theranos, Inc. Point-of-care fluidic systems and uses thereof
WO2007061448A2 (en) 2005-05-18 2007-05-31 President And Fellows Of Harvard College Fabrication of conductive pathways, microcircuits and microstructures in microfluidic networks
US20070073590A1 (en) 2005-08-22 2007-03-29 Cosentino Louis C Remote monitor for physiological parameters and durable medical supplies
US8741230B2 (en) 2006-03-24 2014-06-03 Theranos, Inc. Systems and methods of sample processing and fluid control in a fluidic system
US8012744B2 (en) 2006-10-13 2011-09-06 Theranos, Inc. Reducing optical interference in a fluidic device
JP4999613B2 (en) 2007-08-31 2012-08-15 シスメックス株式会社 Blood coagulation measurement reagent and blood coagulation time measurement method
EP3181228B1 (en) * 2007-10-02 2020-07-29 Labrador Diagnostics LLC Modular point-of-care devices and uses thereof
US8372343B2 (en) 2007-12-07 2013-02-12 Sheldon Goldstein Multiple coagulation test cartridge and method of using same
MX337333B (en) 2008-03-26 2016-02-26 Theranos Inc Methods and systems for assessing clinical outcomes.
WO2009135205A2 (en) * 2008-05-02 2009-11-05 Advanced Liquid Logic, Inc. Droplet actuator techniques using coagulatable samples
EP2304414B1 (en) 2008-07-24 2017-03-15 The Trustees of Princeton University Bump array device having asymmetric gaps for segregation of particles
JP5465850B2 (en) 2008-08-01 2014-04-09 シスメックス株式会社 Sample analysis system
EP2214011B1 (en) * 2008-08-01 2019-01-02 Sysmex Corporation Blood sample analyzing apparatus
EP2177624A1 (en) * 2008-10-02 2010-04-21 Siemens Healthcare Diagnostics Products GmbH Blood coagulation assays
JP5926958B2 (en) * 2008-10-29 2016-05-25 ティー2 バイオシステムズ,インコーポレーテッド NMR detection of coagulation time
FR2943789B1 (en) 2009-03-26 2013-07-26 Commissariat Energie Atomique METHOD AND DEVICE FOR CHARACTERIZING THE DYNAMIC OF COAGULATION OR SEDIMENTATION OF A FLUID SUCH AS BLOOD OR BLOOD PLASMA
JP2010266236A (en) * 2009-05-12 2010-11-25 Sysmex Corp Device for analysis of sample
NZ624935A (en) 2009-10-19 2016-01-29 Theranos Inc Integrated health data capture and analysis system
US20110166875A1 (en) * 2010-01-05 2011-07-07 Abbott Diabetes Care Inc. System and method for managing medical data and facilitating reimbursement for health care
RU2620922C2 (en) 2011-01-21 2017-05-30 Теранос, Инк. Systems and methods for optimization of sample use
US8697449B2 (en) * 2011-04-01 2014-04-15 Spectral Sciences, Inc. Optical blood coagulation monitor and method
US8435738B2 (en) 2011-09-25 2013-05-07 Theranos, Inc. Systems and methods for multi-analysis
US9500639B2 (en) 2012-07-18 2016-11-22 Theranos, Inc. Low-volume coagulation assay

Also Published As

Publication number Publication date
JP2019002939A (en) 2019-01-10
CA3124500A1 (en) 2014-01-23
US20220137075A1 (en) 2022-05-05
EP2875146B1 (en) 2022-05-18
BR112015001048A8 (en) 2021-07-06
US9500639B2 (en) 2016-11-22
IL236768B (en) 2019-10-31
SG10201603916UA (en) 2016-07-28
US20140087403A1 (en) 2014-03-27
EP2875146A2 (en) 2015-05-27
CN109884289B (en) 2022-07-26
BR112015001048B1 (en) 2021-12-14
WO2014015191A3 (en) 2014-05-08
BR112015001048A2 (en) 2017-06-27
JP2022116194A (en) 2022-08-09
WO2014015191A2 (en) 2014-01-23
KR102149318B1 (en) 2020-10-14
CA2878875C (en) 2021-09-07
CN109884289A (en) 2019-06-14
CA2878875A1 (en) 2014-01-23
IL236768A0 (en) 2015-03-31
AU2013292392A1 (en) 2015-01-29
US20150301018A1 (en) 2015-10-22
MX360564B (en) 2018-11-07
JP2021009153A (en) 2021-01-28
JP2015528911A (en) 2015-10-01
CN104662163A (en) 2015-05-27
KR20150034793A (en) 2015-04-03
EP2875146A4 (en) 2016-03-02
MX2015000808A (en) 2015-05-07
US11119110B2 (en) 2021-09-14
HK1210812A1 (en) 2016-05-06
US20170023594A1 (en) 2017-01-26

Similar Documents

Publication Publication Date Title
HK1210812A1 (en) Low-volume coagulation assay
HRP20171401T1 (en) Disposable circumcising anastomat
HK1213047A1 (en) Improved assay methods
GB201310691D0 (en) Assay
EP2932696A4 (en) Assay apparatus
EP2890427A4 (en) Electrochemically-actuated microfluidic devices
GB201304810D0 (en) Assay
GB201215571D0 (en) Assay method
AP2015008602A0 (en) Truss configuration
GB201203938D0 (en) Assay system
EP2981823A4 (en) Novel Assay
PL2626134T3 (en) Pipette
GB201212528D0 (en) Assay
GB201209664D0 (en) Assay device
EP2844770A4 (en) Mrm-ms signature assay
GB201216122D0 (en) Screening assay
GB201315011D0 (en) Assay
GB201221011D0 (en) Assay method
GB201219024D0 (en) Assay
GB201213229D0 (en) Assay
GB201212778D0 (en) Assay
AP00418S1 (en) Assay devices
GB201314951D0 (en) Assay
GB201312918D0 (en) Assay
GB201309760D0 (en) Assay